Renal Disease news from FierceHealthcare
NewsAfrican Americans face greater risk of hospital readmission
Hospitalized patients who are African American and/or on Medicaid face a greater chance of being readmitted to a hospital within one month of their first discharge, according to a new study published Read more...
Reform bills may extend Medicare coverage for kidney transplant drugs
Since 1973, Medicare has covered treatment for any American citizen with end-stage renal disease, and 80 percent the bill for costly immunosuppressive medications. However, CMS will only pay the bill Read more...
Dialysis for illegal immigrants becomes issue in Las Vegas
Talk about finding a way to stir up strong feelings. A daily newspaper serving Las Vegas has published an article noting that a taxpayer-supported medical center spends $20 million a year, and that Read more...
Bill challenges Medicare limit on meds for kidney recipients
This week, two Senators introduced a bill that would require Medicare to cover high-ticket drugs used to support kidney transplant patients for the life of the transplanted kidney. The bill would Read more...
| Press ReleasesDaVita Announces Government InquiryDENVER--(BUSINESS WIRE)-- DaVita Inc. (NYSE: DVA), (the “Company”), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced today that it has been Read more >> CJPS Medical Systems Shakes the World of TelemedicineAUBURN HILLS, Mich.--(BUSINESS WIRE)-- In an unprecedented move, CJPS Medical Systems announces that it will no longer charge for any connectivity fees for caregivers to access patient data when Read more >> Satellite Dialysis Enrolls 100 Patients in Innovative Nocturnal Dialysis ProgramRecent Survey by Satellite Healthcare Researchers Shows Nocturnal Dialysis Leads to Improved Quality of Life, Other Benefits for Patients SAN JOSE, Calif.--(BUSINESS WIRE)-- Satellite Healthcare, one Read more >> DaVita Reports on Corporate Social Responsibility Efforts2010 Report Highlights DaVita’s Vision for Building Shared Value with Communities DENVER--(BUSINESS WIRE)-- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed Read more >> Unmet Need for Safe, Efficient Kidney and Renal Disease Treatments: companiesandmarkets.comLimited competition in kidney and renal disease drug marketHigh unmet need for drugs with strong safety and tolerability profilesSerious side effects noted with use of sevelamer carbonate, lanthanum Read more >> |
